Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Glsem1/Cya
Common Name:
Gls-KO
Product ID:
S-KO-02262
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Gls-KO
Strain ID
KOCMP-14660-Gls-B6J-VA
Gene Name
Gls
Product ID
S-KO-02262
Gene Alias
6330442B14; B230365M23Rik
Background
C57BL/6JCya
NCBI ID
14660
Modification
Conventional knockout
Chromosome
1
Phenotype
MGI:95752
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Glsem1/Cya mice (Catalog S-KO-02262) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000114513
NCBI RefSeq
NM_001081081
Target Region
Exon 4
Size of Effective Region
~0.1 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Gls, also known as glutaminase, is an enzyme that converts glutamine into glutamate [2]. Glutamate is the most abundant central nervous system neurotransmitter, and thus Gls plays a crucial role in maintaining glutamate homeostasis [2,6]. The enzyme is involved in various biological processes, and its activity is closely related to metabolism, cell growth, and development [1,3]. Altered glutamine metabolism, with Gls as a key regulator, has been linked to the development of many diseases [3].

In cancer research, Gls shows promise as a biomarker and potential therapeutic target. In breast cancer, it is aberrantly over-expressed, has a high ROC-AUC value for diagnosis, and is related to tumor growth, metastasis, and the immune tumor microenvironment [1]. In prostate cancer, Gls is up-regulated, and its knockdown suppresses cell proliferation, promotes apoptosis, and arrests the cell cycle, also suppressing the Wnt/β-catenin pathway [3]. In lung cancer, certain Gls gene polymorphisms are associated with reduced susceptibility [5]. In acute myocardial infarction, Gls has good diagnostic value and is associated with immune-and hypoxia-related pathways [4]. Loss-of-function mutations in Gls can cause autosomal recessive spastic ataxia and optic atrophy [6], while a gain-of-function variant leads to glutamate excess, infantile cataract, and profound developmental delay [2].

In conclusion, Gls is essential for maintaining glutamate homeostasis and is involved in multiple biological processes. Its dysregulation is associated with various diseases, including cancer, neurodegenerative disorders, and metabolic diseases. Functional studies, especially those using loss-of-function models, have provided valuable insights into its role in disease development, highlighting its potential as a diagnostic biomarker and therapeutic target.

References:

1. Zhang, Danfeng, Wang, Man, Huang, Xufeng, Li, Zhengrui, Wang, Geng. 2023. GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights. In Frontiers in oncology, 13, 1220038. doi:10.3389/fonc.2023.1220038. https://pubmed.ncbi.nlm.nih.gov/37664031/

2. Rumping, Lynne, Tessadori, Federico, Pouwels, Petra J W, Jans, Judith J M, van Hasselt, Peter M. . GLS hyperactivity causes glutamate excess, infantile cataract and profound developmental delay. In Human molecular genetics, 28, 96-104. doi:10.1093/hmg/ddy330. https://pubmed.ncbi.nlm.nih.gov/30239721/

3. Zhang, Junfeng, Mao, Shiyu, Guo, Yadong, Yao, Xudong, Huang, Yong. 2019. Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer. In Bioscience reports, 39, . doi:10.1042/BSR20181826. https://pubmed.ncbi.nlm.nih.gov/31196962/

4. Liu, Zheng, Wang, Lei, Xing, Qichang, Liu, Renzhu, Huang, Nan. 2022. Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction. In Frontiers in cardiovascular medicine, 9, 1016081. doi:10.3389/fcvm.2022.1016081. https://pubmed.ncbi.nlm.nih.gov/36440046/

5. Wang, Yuhe, Chen, Mingyue, Yi, Faling, Jin, Tianbo, Chen, Mingwei. . Association between GLS Gene Polymorphisms and the Susceptibility to Lung Cancer in the Chinese Han Population. In Frontiers in bioscience (Landmark edition), 28, 95. doi:10.31083/j.fbl2805095. https://pubmed.ncbi.nlm.nih.gov/37258469/

6. Lynch, David S, Chelban, Viorica, Vandrovcova, Jana, Wood, Nicholas W, Houlden, Henry. 2018. GLS loss of function causes autosomal recessive spastic ataxia and optic atrophy. In Annals of clinical and translational neurology, 5, 216-221. doi:10.1002/acn3.522. https://pubmed.ncbi.nlm.nih.gov/29468182/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest